Showing results (511-520 of 579) with videos related to

Sort By:
Pageof 58
Leukemia Research|December 29, 2015
BCL11A expression in acute myeloid leukemiaHuiquan Tao, Xiao Ma, Guangsong Su, et al.
American Journal of Hematology|February 3, 2022
Anti-CD19 and anti-BCMA CAR T cell therapy followed by lenalidomide maintenance after autologous stem-cell transplantation for high-risk newly diagnosed multiple myelomaXiaolan Shi, Lingzhi Yan, Jingjing Shang, et al.
Molecular Carcinogenesis|January 11, 2021
Identification of a novel TNRC18-RARA fusion in acute promyelocytic leukemia lacking t(15;17)(q24;q12)/PML-RARAZheng Wang, Lijun Wen, Ling Zhang, et al.
Haematologica|May 13, 2014
Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Norbert-Claude Gorin, et al.
JCI Insight|July 24, 2019
Comparation of CART19 and autologous stem-cell transplantation for refractory/relapsed non-Hodgkin's lymphomaCaixia Li, Ying Zhang, Changfeng Zhang, et al.
Cancer Communications (London, England)|January 22, 2021
Outcomes in refractory diffuse large B-cell lymphoma: results from a multicenter real-world study in ChinaShuo Wang, Li Wang, Jianda Hu, et al.
Cell Death and Differentiation|May 16, 2021
Kupffer cell receptor CLEC4F is important for the destruction of desialylated platelets in miceYizhi Jiang, Yaqiong Tang, Christopher Hoover, et al.
Blood Advances|March 1, 2021
Low-dose decitabine for refractory prolonged isolated thrombocytopenia after HCT: a randomized multicenter trialYaqiong Tang, Jia Chen, Qifa Liu, et al.
Hemasphere|April 14, 2025
Improved post-transplant outcomes since 2000 for Ph-positive acute lymphoblastic leukemia in first remission: A study from the EBMT Acute Leukemia Working PartyAli Bazarbachi, Myriam Labopin, Iman Abou Dalle, et al.
Oncoimmunology|April 14, 2017
Combining therapeutic antibodies using basiliximab and etanercept for severe steroid-refractory acute graft-versus-host disease: A multi-center prospective studyYamin Tan, Haowen Xiao, Depei Wu, et al.
Pageof 58